Federated Hermes, Inc. T2 Biosystems, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.47 - $3.16 $811 - $1,744	-552 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$2.98 - $6.86 $1,475 - $3,395	-495 Reduced 47.28%	552 $1,000
Q3 2018 Nov 13, 2018	SELL	$5.36 - $7.83 $5,268 - $7,696	-983 Reduced 48.42%	1,047 $8,000
Q2 2018 Aug 10, 2018	BUY	$5.97 - $9.58 $1,164 - $1,868	195 Added 10.63%	2,030 $16,000
Q1 2018 May 09, 2018	BUY	$4.21 - $7.0 $7,725 - $12,845	1,835 New	1,835 $12,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.88M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.